Article
ApoE Inhibits the Progression of Glioma by Activating Immune Function
1 Jul 2025
Abstract excerpt
Glioma, marked by a low mutational burden, low immunogenicity, high heterogeneity, and the challenges posed by the blood-brain barrier, continues to be a major hurdle in neuro-oncology. Current research underscores the necessity for more effective medications and treatment strategies. In this study, we explored the role of Apolipoprotein E (ApoE) in glioma using both bioinformatics and experimental methods. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
